San Francisco, CA - UCSF and the Cell Technologies business of GE Healthcare Life Sciences have begun a unique collaboration aimed at overcoming the lack of blood-forming stem cells available to patients suffering from life-threatening diseases such as lymphoma, myeloma, leukemia or sickle cell anemia. The goal of the $840,000, three-year project is to make better use of a rich source of routinely discarded stem cells: umbilical cord blood from the birth of a baby.
Supported by GE and Science
WASHINGTON, DC -- For his novel approach to creating maps that enable researchers to zoom in on the human genome and reveal features of DNA structure inside the nucleus, Erez Lieberman Aiden has been named the 2011 Grand Prize winner for the GE & Science Prize for Young Life Scientists. The annual competition includes a grand-prize award of $25,000 and is supported by GE Healthcare and the journal Science, which is published by AAAS, the nonprofit science society.
business unit
tags
COPENHAGEN, DENMARK and CHALFONT St. GILES, UK -- 17 October, 2011 - Affitech A/S (NASDAQ OMX: AFFI) and GE Healthcare Life Sciences announced today that GE Healthcare Life Sciences has executed an exclusive license for the worldwide marketing and sales of products containing recombinant Protein L, granted by Affitech in a patent and know-how license agreement. Under the terms of the agreement, GE Healthcare Life Sciences agrees to pay Affitech a royalty of the net sales of all related products sold by GE Healthcare Life Sciences.
business unit
tags
Cardiff, UK -- 27 September 2011 - Kay Swinburne, MEP visited GE Healthcare's Maynard Centre in Cardiff, Wales on Friday 23rd September. The Maynard Centre, operational since 1980 and with approximately 450 employees, is a key research and manufacturing facility for GE Healthcare's Life Sciences business.
business unit
tags
* Agreement covers intellectual property relating to biopharmaceutical manufacturing technologies
Aubagne, France; Goettingen, Germany and Chalfont St. Giles, UK - September 12, 2011 -- Sartorius Stedim Biotech has entered into a patent cross-licensing agreement with GE Healthcare Life Sciences. This will enable the further development of each company's current and future biopharmaceutical manufacturing technologies.
business unit
tags
(Trenton, NJ) -- Lt. Governor Kim Guadagno today continued her "100 Businesses Initiative" with a visit to the North American hub of GE Healthcare Life Sciences in Piscataway. This is one in the series of 100 meetings around New Jersey that the Lt. Governor will personally make with business owners and local leaders.